RECOVERY Collaborative Group 2023, ' Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. ', Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507 . https://doi.org/10.1016/S0140-6736(23)00510-X
Mumford, A D & Gibbison, B J J 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 Dimitriadis, G K 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 RECOVERY Collaborative Group & Dark, P 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet . https://doi.org/10.1016/S0140-6736(22)01109-6
RECOVERY Collaborative Group & Downey, D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', The Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Mumford, A D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Lancet (London, England) Group, RECOVERY C, Felton, T, Dark, P & Mathioudakis, A 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5
Thygesen, JH, Hollings, S, Mizani, MA, Handy, A, Akbari, A, Banerjee, A, Mateen, BA, Sattar, N, Sofat, R, Torralbo, A, Steeg, S & Consortium, L H A W COVID N C S A T CVD-COVID-UKCOVID-IMPACT 2022, ' COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records. ', The Lancet Digital health, vol. 4, no. 7, pp. e542-e557 . https://doi.org/10.1016/S2589-7500(22)00091-7 Thygesen, J H, Tomlinson, C, Hollings, S, Mizani, M, Handy, A, Akbari, A, Banerjee, A, Cooper, J A, Lai, A, Li, K, Mateen, B A, Sattar, N, Sofat, R, Torralbo, A, Wu, H, Wood, A, Sterne, J A C, Pagel, C, Whiteley, W N, Sudlow, C L M, Hemingway, H & Denaxas, S 2022, ' COVID-19 trajectories among 57 million adults in England : a cohort study using electronic health records ', The Lancet. Digital health, vol. 4, no. 7, pp. e542-e557 . https://doi.org/10.1016/S2589-7500(22)00091-7 The Lancet. Digital health Thygesen, J H, Tomlinson, C, Hollings, S, Mizani, MA, Handy, A, Akbari, A, Banerjee, A, Cooper, J, Lai, A G, Li, K, Mateen, B A, Sattar, N, Sofat, R, Torralbo, A, Wu, H, Wood, A M, Sterne, J A C, Pagel, C, Whiteley, W N, Sudlow, C L M, Hemingway, H, Denaxas, S, Consortium, CVD-COVID UK & National Core Study, COVID 2022, ' COVID-19 trajectories among 57 million adults in England : a cohort study using electronic health records ', The Lancet Digital Health, vol. 4, no. 7, pp. e542-e557 . https://doi.org/10.1016/S2589-7500(22)00091-7
RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5